Most studies on Chiari malformation (CM) are focused on CM Type-1. A new subtype, CM Type-1.5, lacks sufficient research. This study aims to evaluate the long-term surgical outcomes of posterior fossa decompression followed by duraplasty with arachnoid-preserving (PFDD-AP) technique for primary and recurrent CM Type-1.5.
MethodsThe medical charts of patients treated surgically for CM at our institute between January 2011 and January 2022 were reviewed retrospectively. Adult patients consecutively treated for CM Type-1.5 were selected as the core sample for the current study. Group A included primary cases (i.e., patients who had not previously been surgically treated), and Group B included recurrent cases. The surgical outcomes were compared by evaluating clinical and radiological findings.
ResultsThirty-four CM Type-1.5 cases out of 202 CM cases met the study criteria. Twenty-three and 11 cases represented Group A and Group B, respectively. The female-to-male ratio was 2/1. In Group B, the preoperative herniated tonsil extension and the obex position were statistically significantly longer, and retroversion and retroflexion angles were statistically considerably smaller ([p = 0.024; Z = − 2.26]; [p = 0.023; Z = − 2.27]; [p = 0.031; Z = − 2.29]; and [p = 0.0002; Z = − 3.72], respectively). For the cases presented with syringomyelia (SM) in both groups (n = 20), total and partial regression were recorded postoperatively in 65% and 15% of cases, respectively. The satisfactory recovery or improvement rate in neurological symptoms was 94.1%.
DiscussionTotal or partial SM regression occurred following PFDD-AP in most adult patients with CM Type-1.5 who presented with SM. The PFDD-AP approach offers better results with fewer complications and recurrence rates.
Keywords Chiari malformation Type-1.5 - posterior fossa decompression - duraplasty with arachnoid-preserving technique - syringomyelia - recovery - recurrent Chiari malformation NoteThis work was carried out at the Department of Neurosurgery, Atlas University–Medicine Hospital.
This comparative retrospective study was approved under decision number: (E-22686390-050.99-26421/2023) by the medical ethics committee of Atlas University, Istanbul, Turkey.
*All authors contributed equally to this work and deserve the first name.
Publication HistoryReceived: 06 February 2025
Accepted: 16 April 2025
Accepted Manuscript online:
17 April 2025
Article published online:
26 June 2025
© 2025. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Comments (0)